Triglyceride as a risk factor for ischaemic heart disease in British men: Effect of adjusting for measurement error

Atherosclerosis

Volumn 143, Issue 2, 1999, Pages 275-284

  Egger, Matthias ^a,b   Smith, George Davey ^a   Pfluger, Dominik ^b   Altpeter, Ekkehardt ^b   Elwood, Peter C ^a,c  

^a Ctr for Living Info Syst Thinking   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Coronary disease; Lipids; Measurement error; Men; Statistical models

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANALYTICAL ERROR; ARTICLE; BODY MASS; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; STATISTICAL ANALYSIS; UNITED KINGDOM;

ADULT; AGE FACTORS; CHOLESTEROL, HDL; COHORT STUDIES; CONFIDENCE INTERVALS; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TRIGLYCERIDES;

EID: 0032947470     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00300-1     Document Type: Article

References (53)

1. Hulley S.B., Rosenman R.H., Bawol R.D., Brand R.J. Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease. New Engl J Med. 302:1980;1383-1389.
2. Fuller W.A., Hidiroglou M.A. Regression estimates after correcting for attenuation. J Am Stat Assoc. 73:1978;99-104.
3. Phillips A.N., Davey Smith G. Bias in relative odds estimation due to imprecise measurement of correlated exposures. Stat Med. 11:1992;953-961.
4. Davey Smith G., Phillips A.N. Confounding in epidemiological studies: why 'independent' effects may not be all they seem. Br Med J. 305:1992;757-759.
5. Willett W. An overview of issues related to the correction of non-differential exposure measurement error in epidemiologic studies. Stat Med. 8:1989;1031-1040.
6. Spearman C. The proof and measurement of association between two things. Am J Psychol. 15:1904;72-101.
7. McMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective epidemiological studies corrected for the regression dilution bias. Lancet. 335:1990;765-774.
8. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol. 112:1980;564-569.
9. Kupper L.L. Effects of the use of unreliable surrogate variables on the validity of epidemiologic research studies. Am J Epidemiol. 120:1984;643-648.
10. Mogadam M., Ahmed S.W., Mensch A.H., Godwin I.D. Within-person fluctuations of serum cholesterol and lipoproteins. Arch Intern Med. 150:1990;1645-1648.
11. Phillips A.N., Davey Smith G. How independent are 'independent' effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 44:1991;1223-1231.
12. Betteridge D.J. Lipoproteins and coronary heart disease. J Hum Hypertens. 3(suppl 2):1989;13-25.
13. Criqui M.H., Heiss G., Cohn R., Cowan L.D., Suchindran C.M., Bangdiwala S., Kritchevsky S., Jacobs D.R. Jr, O'Grady H.K., Davis C.E. Plasma triglyceride levels and mortality from coronary heart disease. New Engl J Med. 328:1993;1220-1225.
14. Sattar N., Packard C.J., Petrie J.R. The end of triglycerides in cardiovascular risk assessment? Br Med J. 317:1998;553-554.
15. Riemersma R.A. Coronary artery disease: raised cholesterol or triglycerides? Int J Cardiol. 5:1984;193-194.
16. Austin M.A. Plasma triglycerides as a risk-factor for coronary heart disease. The epidemiological evidence and beyond. Am J Epidemiol. 129:1989;249-259.
17. Bainton D., Miller N.E., Bolton C.H., Yarnell J.W.G., Sweetnam P.M., Baker I.A. Lewis B, Elwood PC. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. Br Heart J. 68:1992;60-66.
18. Abbott R.D., Carroll R.J. Interpreting multiple logistic regression coefficients in prospective observational studies. Am J Epidemiol. 119:1984;830-836.
19. Elwood P.C., Burr M.L., Bainton D., Yarnell J.W.G., Fehily A.M., Baker I.A., Sweetnam P.M. Epidemiological studies of cardiovascular diseases. Progress report VII. 1991;1991 MRC Epidemiology Unit, Cardiff.
20. Caerphilly and Speedwell collaborative heart disease studies. J Epidemiol Community Health. 38:1984;259-262.
21. Rose G.A. Chest pain questionnaire. Millbank Memorial Fund Quarterly. 43:1965;32-39.
22. Steele B.W., Koehler D.F., Kuba K., Azar M.M. An enzymatic approach to lipoprotein quantification. Am J Clin Pathol. 73:1980;75-78.
23. Buccolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:1973;476-482.
24. Lopes-Virella M.F., Stone P., Ellis S., Colwell J.A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 23:1977;822-824.
25. Kadish A.H., Little R.L., Sternberg J.C. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 14:1968;116-131.
26. Hosmer D.W., Lemeshow S. Applied logistic regression. 1989;John Wiley, New York.
27. Cox D.R. Regression models and life tables. J R Stat Soc. 34:1972;187-220.
28. Rosner B., Spiegelman D., Willett W. Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. Am J Epidemiol. 132:1990;734-745.
29. Rosner B., Spiegleman D., Willett W.C. Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol. 136:1992;1400-1413.
30. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. i:1986;307-310.
31. De Klerk N.H., English D.R., Armstrong B.K. A review of the effects of random measurement error on relative risk estimates in epidemiological studies. Int J Epidemiol. 18:1989;705-712.
32. Rosner B., Willett W.C., Spiegelman D. Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med. 8:1989;1051-1069.
33. SAS Institute. SAS language guide for personal computers, Version 6. Cary, NC: SAS Institute, 1985.
34. Albrink M.J., Man E.B. Serum triglycerides in coronary artery disease. Arch Intern Med. 103:1959;4-8.
35. Triglyceride, high-density lipoprotein, and coronary heart disease. J Am Med Assoc. 269:1993;505-510.
36. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 3:1997;213-219.
37. Jacobs D.R., Barrett-Connor E. Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinic Prevalence Study. Am J Epidemiol. 116:1982;878-885.
38. Prentice R.L. Covariate measurement errors and parameter estimation in a failure time regression model. Biometrika. 69:1982;331-342.
39. Armstrong B. Measurement error in generalized linear models. Commun Stat Ser B. 14:1996;529-544.
40. Patsch J.R., Prasad S., Gotto A.M., Patsch W. High density lipoprotein - relationship of the plasma levels of this lipoportein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest. 80:1987;341-347.
41. Glomset J.A. The plasma lecithin cholesterol acetyltransferase reaction. J Lipid Res. 9:1968;155-167.
42. Stampfer M.J., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M. et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. J Am Med Assoc. 276:1996;882-888.
43. Meade T.W., Brozovic M., Chakrabarti R.R., Haines A.P., Imeson J.D., Mellows S., Miller G.J., North W.R. Haemostatic function and ischaemic heart disease: principal results of the northwick park heart study. Lancet. 6:1986;533-537.
44. Baker I.A., Sweetnam P.M., Yarnell J.W.G., Bainton D., Elwood P.C. Haemostatic and other risk factors for ischaemic heart disease and social class: evidence from the Caerphiily and Speedwell studies. Int J Epidemiol. 17:1988;759-765.
45. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation. 60:1979;473-485.
46. Slyper A.H. A fresh look at the atherogenic remnant hypothesis. Lancet. 340:1992;289-291.
47. Uiterwaal C.S.P.M., Grobbee D.E., Witteman J.C.M., van Stiphout W.-A.H.J., Krauss X.H., Havekes L.M., de Bruijn A.M., van Tol A. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med. 121:1994;576-583.
48. Sharrett A.R., Patsch W., Sorlie P.D., Heiss G., Bond M.G., Davis C.E. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. Arterioscler Thromb. 14:1994;1098-1104.
49. Yarnell J.W., Pickering J.E., Elwood P.C., Baker I.A., Bainton D., Dawkins C., Phillips D.I. Does non-diabetic hyperglycaemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol. 47:1994;383-388.
50. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
51. Tenkanen L., Pietilä K., Manninen V., Mänttäri M. The triglyceride issue revisited. Findings from the Helsinki Heart Study. Arch Intern Med. 154:1994;2714-2720.
52. Garg A. Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care. 19:1996;387-389.
53. Yarnell J.W.G., Sweetnam P.M., Marks V., Teale J.D., Bolton C.H. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J. 71:1994;293-296.